People Briefs: NuVasive, Delcath, Boston Scientific, Silk Road, Si-Bone
This article was originally published in The Gray Sheet
Executive Summary
NuVasive and Delcath Systems appoint CEOs. Boston Scientific Corp. names senior medical director, rhythm management. Silk Road Medical Inc. appoints executive VP, global sales. Si-Bone taps CFO.
You may also be interested in...
People Briefs
Cohera Medical CEO named AdvaMed Accel chair; Trovagene sacks CEO and CFO over precision medicine dispute; OraSure Technologies appoints Eamonn Hobbs to board; DNA Diagnostics Center names its president and CEO; Lantheus Holdings taps CFO; Omcron gets new president and CEO.
New Product Briefs
Product news from Silk Road Medical, EnteroMedics, St. Jude, Tandem Diabetes and Abbott.
Next Steps For NuVasive Following CEO Resignation
The resignation of CEO Alex Lukianov could signal a shift in the spine firm's approach to sales and profitability that could ultimately make NuVasive as a more attractive acquisition candidate.